Information for "Ocrelizumab"
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Display title | Ocrelizumab |
Default sort key | Ocrelizumab |
Page length (in bytes) | 1,492 |
Page ID | 2124 |
Page content language | en - English |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 1 |
Counted as a content page | Yes |
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
View the protection log for this page.
Page creator | Ollie (talk | contribs) |
Date of page creation | 08:11, June 25, 2016 |
Latest editor | Kmdenmark (talk | contribs) |
Date of latest edit | 21:28, March 5, 2021 |
Total number of edits | 17 |
Total number of distinct authors | 5 |
Recent number of edits (within past 90 days) | 0 |
Recent number of distinct authors | 0 |
Hidden categories (2) | This page is a member of 2 hidden categories:
|
Transcluded templates (20) | Templates used on this page:
|